Using new methods (1-9), we and others have studied directly the binding of many polypeptide hormones to specific receptors on cells (10) . The specificity of binding correlates well with the biological activity of the hormone. Typically, binding is rapid saturable, and reversible (e.g., Fig. 1 ) and represented as a simple biomolecular reaction, hormone + receptor T4 hormone-receptor complex. Recently, Archer, GoldfRne, Iahn, and others have found that the concentration of insulin receptors per cell fluctuates in response to altered conditions in vivo (11-23). Fasting or hypophysectomy is followed by an increase in the concentration of insulin receptors per cell (20, 22) associated with the hypoinsulinemia and the supernormal sensitivity to injected insulin that characterize these states; the increase in receptor concentration per cell correlates with increased sensitivity to insulin in vitro (20). Conversely, obesity or glucocorticoid excess, states that are characterized by chronic hyperinsulinemia and insulin resistance, are associated with large decrements in insulin receptors but not of other hormone receptors (11, 13, 14, 21) . The loss of receptors is similar in liver, fat, and lymphocytes. Appropriate treatment of the obesity or of the glucocorticoid excess ameliorates the hyperinsulinemia and insulin resistance at the same time that the receptor concentration is restored (15, 16, 22) . In contrast to chronic hyperinsulinemia, acute elevation (up to 1 hr) in plasma insulin in all cases had no effect on the concentration of insulin receptors (11, 13, 14).
Using new methods (1-9), we and others have studied directly the binding of many polypeptide hormones to specific receptors on cells (10) . The specificity of binding correlates well with the biological activity of the hormone. Typically, binding is rapid saturable, and reversible (e.g., Fig. 1 ) and represented as a simple biomolecular reaction, hormone + receptor T4 hormone-receptor complex.
Recently, Archer, GoldfRne, Iahn, and others have found that the concentration of insulin receptors per cell fluctuates in response to altered conditions in vivo (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Fasting or hypophysectomy is followed by an increase in the concentration of insulin receptors per cell (20, 22) associated with the hypoinsulinemia and the supernormal sensitivity to injected insulin that characterize these states; the increase in receptor concentration per cell correlates with increased sensitivity to insulin in vitro (20) . Conversely, obesity or glucocorticoid excess, states that are characterized by chronic hyperinsulinemia and insulin resistance, are associated with large decrements in insulin receptors but not of other hormone receptors (11, 13, 14, 21) . The loss of receptors is similar in liver, fat, and lymphocytes. Appropriate treatment of the obesity or of the glucocorticoid excess ameliorates the hyperinsulinemia and insulin resistance at the same time that the receptor concentration is restored (15, 16, 22) . In contrast to chronic hyperinsulinemia, acute elevation (up to 1 hr) in plasma insulin in all cases had no effect on the concentration of insulin receptors (11, 13, 14) .
In the present study we reproduce this phenomenon in vitro. Cultured lymphocytes that are exposed to chronic elevations in the ambient insulin concentration in the physiological range have a decrement in the concentration of insulin receptors per cell; acute elevations of the ambient insulin concentrations are without effect. Other hormone (e.g., growth hormone) receptor concentrations are unaltered. The time, concentration, and temperature dependence of the process, as well as its reversal, indicates a reciprocal regulatory relationship between the concentration of insulin in the extracellular fluid and the concentration of insulin receptors per cell, and this relationship in vivo affects the sensitivity of the target cell to the hormone.
MATERIALS AND METHODS

Insulin. Solutions of porcine insulin (PJ5589, gift of Eli
Lilly) were prepared in 25 mM Tris-HCl with 0.1 mg/ml of bovine-serum albumin, pH 7.6 ("Tris-albumin buffer").
Biologically active [12'I linsulin was prepared at specific activities of 100-200 ACi/,ug (9, 24) .
Growth of Cultured Lymphocytes. Human lymphocytes (line no. IM-9) were maintained at 370 in Eagle's minimal essential medium supplemented with 10% fetal-calf serum (Grand Island Biological Supply) by feeding twice weekly (25) . For detailed information on these cells, consult Fahey et al. (26) . Cell viability, monitored by trypan blue dye exclusion (27) Fig. 2 are identically shaped, we concluded that the decrease in binding was accounted for by a decrease in the effective concentration of receptors and not by significant alteration in affinity. § This conclusion was confirmed by more formal analysis of the data (28) (Fig. 2 , inset and legend). A lower concentration of insulin (10-9 M), although capable of filling a significant fraction (29) of insulin receptors in lymphocytes and producing biological effects in vivo and in vitro (30) , had no effect during 16 hours of preincubation (Fig. 4) . Concentrations of insulin greater than 108 M (10--7 and 10 M) were more effective more quickly (Figs. 3 
and 1).
These data parallel results in vivo. With insulin at 10-8 M, § From data in these and other studies, we and others (9) the magnitude of the decrement observed here in vitro is the same as that observed with hepatocytes and lymphocytes isolated from hyperinsulinemic insulin-resistant mice (13) port. In each of the five curves, the binding of [125I]insulin was inhibited significantly by as little as 0.6 ng/ml of unlabeled insulin (i0-10M) and half-maximal inhibition of binding occurred with about 6 ng/ml (10-9 M) of unlabeled hormone (Fig. 2) . Contamination would be expected to manifest itself in these curves as a reduction in binding at low hormone concentrations, while at moderately high insulin concentrations all five curves would overlap, but this was not observed.
To show that the decreased binding of labeled insulin cannot be ascribed to unlabeled insulin released from the cells into the medium during the binding assay, cells were preincubated with 10-8 M insulin at 370 for 16 Regeneration of Insulin Binding Capacity. Cells were preincubated with 10-8 M insulin for 16 hr, separated from the insulin-containing growth medium, and washed as described.
One set of insulin-treated cells was resuspended in assay buffer and shown to have decreased binding capacity (see Fig. 4 ). When a companion set of cells was resuspended in fresh insulin-free growth medium and incubated for an additional 16 hr at 370, the cells recovered their full insulin-binding capacity. When the second preincubation was performed in fresh medium but with 10-9 M insulin added, binding capacity increased but was not restored to normal. Thus, 10-9 M insulin, which was insufficient to depress the receptor concentration (Fig. 4) sulin binds rapidly to a fixed set of specific sites on the cell surface. Subsequently the insulin-receptor complex at physiological temperatures in intact cells, through a series of unknown steps, generates the biological responses of the cell to insulin. The present data suggest that one of the effects of insulin on cells is the transmission of a regulatory signal to decrease the concentration of receptors available for binding, and the magnitude of this effect is related to the level of hormone and duration of exposure. The features that distinguish the physicochemical binding process from the hormone receptor-regulatory process are outlined in Table 1 .
The decrease in receptors cannot be ascribed to simple contamination of receptors by insulin added during the preincubation. If it had occurred, there should have been no delay in its onset upon treatment of the cells with 10 M insulin and no progression with time, and it should have been more marked with preincubation at 23°than at 370 (29) . Further, a reduction in binding due to contamination might be expected to alter the shapes of the competition curves, but this did not occur.
The intracellular events initiated by insulin that lead to reduction in the number of sites are unknown, as is the fate of the lost receptors. Possible mechanisms include decreased synthesis, accelerated degradation, release into the medium, translocation to an intracellular site, inaccessibility due to insulin-induced aggregation of the receptor structures, and a metabolic event that includes irreversible binding of insulin to the receptor or intracellular accumulation of insulin. It should be pointed out that "movement" of plasma-membrane surface proteins of lymphocytes can occur upon interaction of these moieties with specific binding proteins added to the incubation medium (31) (32) (33) . This observation has also been extended to specific surface proteins in fibroblasts (34) . Insulin at high concentrations may induce similar perturbations in the morphology of lymphocyte membranes, leading to loss of available receptors. It is also possible that the insulin bound to the receptors may be transported to intracellular compartments by mechanisms similar to those reported for surface immunoglobulins (31) .
The physiological system may be pictured as literally selfmodulating. Protracted elevations of hormone levels cause a decrease in the number of receptors available for insulin binding. Decreases in the number of receptors, and therefore of insulin-mediated messages, may then reduce the insulin effects, including a reduction in the drive to decrease receptors. Thus, each steady-state insulin concentration will produce, after some hours, a steady-state concentration of receptors. We expect that this modulation will be observed at both increased and subnormal insulin concentrations. Even in systems where only a minority of receptor sites need to be filled to achieve the maximal biological response (i.e., where there are "reserve receptors"), the sensitivity of the system to hormone will be altered by an alteration in the receptor concentration. In addition to its modulating effect, this mechanism may be viewed as a safety valve, protecting against persistently high hormone concentrations.
In insulin-resistant states, there is a close correlation between insulin resistance and the basal circulating insulin concentration (35, 36) . It has been generally thought that the resistance is due to circulating peripheral antagonists or to insulin resistance at the tissue level, or both, and that the resistance or antagonism produces hyperinsulinemia by feed- Recent studies have extended this phenomenon of receptor modulation to human growth hormone and its specific receptors (43) . While growth hormone affects its own receptors, it produces no effects on the insulin receptors in these cells, and vice versa. Interestingly with growth hormone, a 50% decrease in receptor concentrations was detectedl after exposure of the cells to concentrations of hormone (10-10 M) that produce occupancy of only 10% of the receptor sites (43) . This may be a general mechanism of modulation for each of the polypeptide hormones. The following observations are cited as a few possible examples of this mechanism in action. In patients with choriocarcinoma or with medullary carcinoma of the thyroid, who have astronomical concentrations of biologically active chorionic gonadotropin or thyrocalcitonin in their circulation, manifestations of hormone excess are usually trivial or absent (44, 45) , whereas, a tiny fraction of this hormone concentration in normal subjects produces significant physiologic effects. In mice that are treated with chorionic gonadotropin for 3 days the uterine weight increases in proportion to the dose of hormone up to a point. Doses in excess of that produce a fall off in the effect, ¶ Lesniak, M. A., Gavin, J. R., III & Roth, J., manuscript in preparation.
so that at very high doses effects are markedly reduced."1 Similarly, ovaries acutely, in vitro, respond equally to luteinizing hormone and to prostaglandin El, measured as activation of adenylate cyclase or as steroidogenesis. Exposure of ovaries to luteinizing hormone for 16 hr in vitro abolished the hormone's responsiveness without any alteration in sensitivity to prostaglandin E1 (46) . Conversely, increased sensitivity to hormone after its removal, e.g., enhanced sensitivity of adrenals to adrenocorticotrophic hormone after hypophysectomy, may also be mediated by this system of direct modulation. Finally, although not every form of hyperinsulinemia produces the same fall in insulin-receptor concentrations (e.g., acromegaly) and not every example of targetcell resistance is due to changes in receptor concentrations (e.g., postnatal development), receptor 
